Pathobiology research at EORTC aims to identify and validate biomarkers across cancer types that can be used to develop new or more targeted treatments. The Pathobiology Group aims to actively contribute to clinical research within EORTC and to perform collaborative studies into biomarkers.


Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.